Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
  1. 4 Planned sale Chief Executive Officer sold 13,012 shares at an average $61.95 ($806,058)
  2. 4 Planned sale Chief Executive Officer sold 19,820 shares at an average $63.14 ($1,251,357)
  3. 4 Planned sale Chief Executive Officer sold 12,791 shares at an average $66.01 ($844,314)
  4. 4 Planned sale Director sold 1,957 shares at an average $64.63 ($126,490)
  5. 4 Planned sale Chief Medical Officer sold 14,183 shares at an average $65.45 ($928,326)
  6. 4 Planned sale Chief Medical Officer sold 9,158 shares at an average $59.64 ($546,153)
  7. 4 Planned sale Director sold 7,337 shares at an average $58.27 ($427,526)
  8. 4 Planned sale Director sold 201 shares at an average $51.31 ($10,312)
  9. 4 Planned sale Chief Medical Officer sold 1,500 shares at $47.41 ($71,115)
  10. 4 Planned sale Director sold 1,957 shares at an average $49.65 ($97,158)
  11. 4 Planned sale Chief Medical Officer sold 1,500 shares at $50.59 ($75,885)
  12. 4 Planned sale Director sold 201 shares at an average $43.44 ($8,731)
  13. 4 Exercise or conversion Chief Executive Officer acquired 3,000 shares (option exercise)
  14. 4 Planned sale Director sold 201 shares at an average $46.04 ($9,253)
  15. 4 Open-market buy Director bought 222,223 shares at $36.00 ($8,000,028)
  16. 4 Open-market buy Director bought 83,334 shares at $36.00 ($3,000,024)
  17. 4 Open-market buy Director bought 83,334 shares at $36.00 ($3,000,024)
  18. 4 Grant or award 10% owner acquired 416,667 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 15 · 283 filings